
NYSEHealthcareMedical - Distribution
أحدث البيانات المتاحة
323.85 US$
+2.50 US$ · +0.78%
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
الإغلاق السابق
323.85 US$
+2.50 US$ · +0.78%
بعد ساعات التداول
323.85 US$
0.00 US$ · 0.00%
9 أكتوبر، 5:49 م ET
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
نطاق اليوم
السعر الحالي 323.85 US$
نطاق 52 أسبوعًا
السعر الحالي 323.85 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
شراء
تقييم
91
قيمة جذابة جدًا
المشاعر
60
مختلط
المخاطر
23
مخاطر متوسطة
الزخم
43
محايد
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
نطاق اليوم
السعر الحالي 323.85 US$
نطاق 52 أسبوعًا
السعر الحالي 323.85 US$
الربحية كنسبة مئوية من الإيرادات المعلنة.
الإيرادات
الدخل التشغيلي
صافي الدخل
| البند (USD) | السنة المالية 2025 | السنة المالية 2024 | السنة المالية 2023 | السنة المالية 2022 | السنة المالية 2021 |
|---|---|---|---|---|---|
| الإيرادات | 321.33 مليار USD | 293.96 مليار USD | 262.17 مليار USD | 238.59 مليار USD | 213.99 مليار USD |
| تكلفة البضاعة المباعة | 311.19 مليار USD | 285.26 مليار USD | 254.42 مليار USD | 230.99 مليار USD | 207.72 مليار USD |
| الربح الإجمالي | 10.14 مليار USD | 8.7 مليار USD | 7.76 مليار USD | 7.6 مليار USD | 6.27 مليار USD |
| مصاريف البيع والمصاريف العمومية والإدارية | 6.49 مليار USD | 5.66 مليار USD | 5.31 مليار USD | 4.85 مليار USD | 3.59 مليار USD |
| نفقات التشغيل | 6.49 مليار USD | 5.66 مليار USD | 5.31 مليار USD | 4.85 مليار USD | 3.59 مليار USD |
| دخل الفوائد | 128.21 مليون USD | 91.69 مليون USD | 46.72 مليون USD | 21.31 مليون USD | 8.47 مليون USD |
| مصاريف الفوائد | 419.75 مليون USD | 248.68 مليون USD | 275.65 مليون USD | 231.98 مليون USD | 182.54 مليون USD |
| الاستهلاك والإطفاء | 1.07 مليار USD | 1.12 مليار USD | 980.85 مليون USD | 709.84 مليون USD | 514.79 مليون USD |
| الدخل التشغيلي | 3.65 مليار USD | 3.04 مليار USD | 2.45 مليار USD | 2.75 مليار USD | 2.68 مليار USD |
| صافي الدخل | 1.55 مليار USD | 1.51 مليار USD | 1.75 مليار USD | 1.7 مليار USD | 1.54 مليار USD |
تم تحديث حقائق الشركة 10 أكتوبر 2026.
أحدث النتائج المعلنة
أحدث النتائج المعلنة
قد تتغير تقديرات المحللين الخارجيين، وهي ليست توصيات من GoAI.
متوسط الهدف
358.14 US$
ارتفاع محتمل بنسبة 10.59%توزيعات نقدية سنوية معدلة للسهم الواحد.
2.25 US$
2025 سنة كاملة-47.9% منذ 2021
2026 سنة جزئية: 1.80 US$
4.32 US$
2,021
1.865 US$
2,022
1.965 US$
2,023
2.08 US$
2,024
2.25 US$
2,025
1.80 US$
2,026*
* سنة تقويمية جزئية ضمن سجل توزيعات الأرباح المتاح.
| الإجراء | تاريخ الاستحقاق | تفاصيل | تاريخ التسجيل | تاريخ الدفع |
|---|---|---|---|---|
توزيعات الأرباح | 14 أغسطس 2026 | 0.60 US$Quarterly | 14 أغسطس 2026 | 31 أغسطس 2026 |
توزيعات الأرباح | 15 مايو 2026 | 0.60 US$Quarterly | 15 مايو 2026 | 1 يونيو 2026 |
توزيعات الأرباح | 13 فبراير 2026 | 0.60 US$Quarterly | 13 فبراير 2026 | 2 مارس 2026 |
توزيعات الأرباح | 14 نوفمبر 2025 | 0.60 US$Quarterly | 14 نوفمبر 2025 | 1 ديسمبر 2025 |
توزيعات الأرباح | 15 أغسطس 2025 | 0.55 US$Quarterly | 15 أغسطس 2025 | 3 سبتمبر 2025 |
توزيعات الأرباح | 16 مايو 2025 | 0.55 US$Quarterly | 16 مايو 2025 | 2 يونيو 2025 |
استحقاق التوزيعات 14 أغسطس 2026
0.60 US$
Quarterly
تاريخ التسجيل 14 أغسطس 2026 · تاريخ الدفع 31 أغسطس 2026
استحقاق التوزيعات 15 مايو 2026
0.60 US$
Quarterly
تاريخ التسجيل 15 مايو 2026 · تاريخ الدفع 1 يونيو 2026
استحقاق التوزيعات 13 فبراير 2026
0.60 US$
Quarterly
تاريخ التسجيل 13 فبراير 2026 · تاريخ الدفع 2 مارس 2026
استحقاق التوزيعات 14 نوفمبر 2025
0.60 US$
Quarterly
تاريخ التسجيل 14 نوفمبر 2025 · تاريخ الدفع 1 ديسمبر 2025
استحقاق التوزيعات 15 أغسطس 2025
0.55 US$
Quarterly
تاريخ التسجيل 15 أغسطس 2025 · تاريخ الدفع 3 سبتمبر 2025
استحقاق التوزيعات 16 مايو 2025
0.55 US$
Quarterly
تاريخ التسجيل 16 مايو 2025 · تاريخ الدفع 2 يونيو 2025
صناديق متداولة تفصح عن تعرضها لهذا السهم.
State Street SPDR S&P 500 ETF1557.T119.08 مليار0.09%129.34 ترليون JPY0.09%122,850 JP¥+0.12%
Vanguard Morningstar Total Stock Market ETFVTI1.9 مليار0.08%2.3 ترليون USD0.03%381.94 US$+0.63%
Vanguard S&P 500 ETFVOO1.67 مليار0.10%1.8 ترليون USD0.03%715.59 US$+0.61%
Vanguard Morningstar Mid-Cap ETFVO1.29 مليار0.57%226.4 مليار USD0.03%81.14 US$+0.92%
iShares Core S&P 500 ETFIVV815.28 مليون0.09%892.79 مليار USD0.03%781.97 US$+0.60%
State Street SPDR S&P 500 ETFSPY752.5 مليون0.09%817.2 مليار USD0.09%778.57 US$+0.60%
Vanguard Morningstar Value ETFVTV571.38 مليون0.22%262.4 مليار USD0.03%220.59 US$+0.44%
State Street Health Care Select Sector SPDR ETFXLV436.14 مليون1.00%43.54 مليار USD0.08%170.81 US$+1.58%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
Vanguard Morningstar Mid-Cap ETFVO
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
Vanguard Morningstar Value ETFVTV
State Street Health Care Select Sector SPDR ETFXLVالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.